Atossa Genetics Current Ratio 2012-2024 | ATOS
Atossa Genetics current ratio from 2012 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Atossa Genetics Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2024-09-30 | $0.08B | $0.01B | 13.30 |
| 2024-06-30 | $0.08B | $0.01B | 14.35 |
| 2024-03-31 | $0.09B | $0.01B | 16.34 |
| 2023-12-31 | $0.09B | $0.01B | 17.61 |
| 2023-09-30 | $0.10B | $0.00B | 28.35 |
| 2023-06-30 | $0.11B | $0.00B | 30.48 |
| 2023-03-31 | $0.11B | $0.00B | 37.66 |
| 2022-12-31 | $0.12B | $0.01B | 21.23 |
| 2022-09-30 | $0.12B | $0.00B | 43.03 |
| 2022-06-30 | $0.13B | $0.00B | 35.19 |
| 2022-03-31 | $0.14B | $0.00B | 58.94 |
| 2021-12-31 | $0.14B | $0.00B | 45.18 |
| 2021-09-30 | $0.14B | $0.00B | 85.33 |
| 2021-06-30 | $0.15B | $0.00B | 81.19 |
| 2021-03-31 | $0.14B | $0.00B | 102.26 |
| 2020-12-31 | $0.04B | $0.02B | 2.73 |
| 2020-09-30 | $0.01B | $0.00B | 7.23 |
| 2020-06-30 | $0.01B | $0.00B | 5.51 |
| 2020-03-31 | $0.01B | $0.00B | 12.85 |
| 2019-12-31 | $0.01B | $0.00B | 10.83 |
| 2019-09-30 | $0.02B | $0.00B | 10.48 |
| 2019-06-30 | $0.02B | $0.00B | 17.80 |
| 2019-03-31 | $0.02B | $0.00B | 13.94 |
| 2018-12-31 | $0.01B | $0.00B | 3.96 |
| 2018-09-30 | $0.01B | $0.00B | 3.92 |
| 2018-06-30 | $0.02B | $0.00B | 5.45 |
| 2018-03-31 | $0.01B | $0.00B | 7.96 |
| 2017-12-31 | $0.01B | $0.00B | 6.45 |
| 2017-09-30 | $0.00B | $0.00B | 2.75 |
| 2017-06-30 | $0.00B | $0.00B | 2.09 |
| 2017-03-31 | $0.00B | $0.00B | 1.96 |
| 2016-12-31 | $0.00B | $0.00B | 3.11 |
| 2016-09-30 | $0.01B | $0.00B | 5.28 |
| 2016-06-30 | $0.00B | $0.00B | 1.66 |
| 2016-03-31 | $0.00B | $0.00B | 2.55 |
| 2015-12-31 | $0.00B | $0.00B | 1.72 |
| 2015-09-30 | $0.01B | $0.00B | 2.90 |
| 2015-06-30 | $0.01B | $0.00B | 4.03 |
| 2015-03-31 | $0.01B | $0.00B | 3.26 |
| 2014-12-31 | $0.01B | $0.00B | 4.13 |
| 2014-09-30 | $0.01B | $0.00B | 7.61 |
| 2014-06-30 | $0.02B | $0.00B | 9.39 |
| 2014-03-31 | $0.02B | $0.00B | 16.36 |
| 2013-12-31 | $0.01B | $0.00B | 4.82 |
| 2013-09-30 | $0.01B | $0.00B | 4.43 |
| 2013-06-30 | $0.01B | $0.00B | 3.02 |
| 2013-03-31 | $0.00B | $0.00B | 2.15 |
| 2012-12-31 | $0.00B | $0.00B | 1.21 |
| 2012-09-30 | $0.00B | $0.00B | 0.39 |
| 2012-06-30 | $0.00B | 0.00 | |
| 2012-03-31 | $0.00B | 0.00 | |
| 2011-12-31 | $0.00B | 0.00 | |
| 2011-09-30 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.147B | $0.000B |
| Atossa Genetics Inc. is a healthcare company focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer. The Company's diagnostic tests consist of medical devices which can collect fluid samples from the breast milk ducts. It is also conducting research on the treatment of pre-cancerous cells by using its FDA-cleared microcatheters to deliver, directly into the milk ducts, anti-cancer drugs that can be used to treat the pre-cancerous lesions. Atossa Genetics Inc. is headquartered in Seattle, WA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $202.293B | 24.68 |
| Intuitive Surgical (ISRG) | United States | $195.881B | 102.41 |
| Edwards Lifesciences (EW) | United States | $43.763B | 27.79 |
| Alcon (ALC) | Switzerland | $43.327B | 28.99 |
| IQVIA Holdings (IQV) | United States | $36.875B | 20.32 |
| IDEXX Laboratories (IDXX) | United States | $35.573B | 41.89 |
| DexCom (DXCM) | United States | $31.642B | 47.65 |
| Waters (WAT) | United States | $23.237B | 34.36 |
| STERIS (STE) | Ireland | $21.444B | 24.69 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.134B | 0.00 |
| Hologic (HOLX) | United States | $17.445B | 18.84 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.790B | 14.16 |
| Sysmex ADR (SSMXY) | Japan | $13.236B | 41.51 |
| Globus Medical (GMED) | United States | $11.494B | 29.11 |
| Penumbra (PEN) | United States | $9.559B | 93.64 |
| Masimo (MASI) | United States | $9.193B | 44.48 |
| Teleflex (TFX) | United States | $8.700B | 13.88 |
| Glaukos (GKOS) | United States | $7.624B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $5.190B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.713B | 26.71 |
| Veracyte (VCYT) | United States | $3.417B | 102.54 |
| Inari Medical (NARI) | United States | $3.056B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.780B | 16.05 |
| TransMedics (TMDX) | United States | $2.423B | 76.82 |
| Nihon Kohden (NHNKY) | Japan | $2.410B | 18.31 |
| Elekta AB (EKTAY) | Sweden | $2.150B | 19.33 |
| Tandem Diabetes Care (TNDM) | United States | $2.120B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.860B | 9.72 |
| RxSight (RXST) | United States | $1.740B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.425B | 0.00 |
| Artivion (AORT) | United States | $1.243B | 82.36 |
| Pulse Biosciences (PLSE) | United States | $1.217B | 0.00 |
| OPKO Health (OPK) | United States | $1.065B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.878B | 14.92 |
| Paragon 28 (FNA) | United States | $0.830B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.716B | 0.00 |
| IRadimed (IRMD) | United States | $0.693B | 37.48 |
| Mesa Laboratories (MLAB) | United States | $0.686B | 16.17 |
| AxoGen (AXGN) | United States | $0.653B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.591B | 0.00 |
| SiBone (SIBN) | United States | $0.578B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.570B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.525B | 30.93 |
| Treace Medical Concepts (TMCI) | United States | $0.502B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.456B | 24.70 |
| Delcath Systems (DCTH) | United States | $0.365B | 0.00 |
| CVRx (CVRX) | United States | $0.359B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.351B | 0.00 |
| NeuroPace (NPCE) | United States | $0.334B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.290B | 0.00 |
| Inogen (INGN) | United States | $0.243B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.210B | 0.00 |
| Accuray (ARAY) | United States | $0.204B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.191B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.181B | 0.00 |
| Nevro (NVRO) | United States | $0.155B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.142B | 15.16 |
| Spectral Diagnostics (EDTXF) | Canada | $0.110B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.097B | 0.00 |
| LENSAR (LNSR) | United States | $0.089B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.086B | 0.00 |
| 908 Devices (MASS) | United States | $0.086B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.085B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.081B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.074B | 0.00 |
| InspireMD (NSPR) | Israel | $0.074B | 0.00 |
| Hyperfine (HYPR) | United States | $0.071B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.053B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.052B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.046B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.043B | 0.00 |
| Envoy Medical (COCH) | United States | $0.043B | 0.00 |
| Spectral AI (MDAI) | United States | $0.040B | 0.00 |
| Neuronetics (STIM) | United States | $0.036B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.026B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.024B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.015B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.014B | 0.00 | |
| Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.011B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |